Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acute demyelinating polyneuropathy induced by nivolumab.

× No keyword cloud information.

7 in total

Review 1. Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibition.

Authors: Peter Chei-Way Pan; Aya Haggiagi
Journal: Curr Oncol Rep Date: 2019-11-27 Impact factor: 5.075

Review 2. Neurological disorders associated with immune checkpoint inhibitors: an association with autoantibodies.

Authors: Morinobu Seki; Shigehisa Kitano; Shigeaki Suzuki
Journal: Cancer Immunol Immunother Date: 2021-09-13 Impact factor: 6.968

Review 3. Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors.

Authors: Justin C Kao; Adipong Brickshawana; Teerin Liewluck
Journal: Curr Neurol Neurosci Rep Date: 2018-08-04 Impact factor: 5.081

4. Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies.

Authors: Shohei Watanabe; Kazuki Yoshizumi; Sayaka Moriguchi; Tomoki Higashiyama; Yoshiki Negi; Koji Mikami; Takashi Kimura
Journal: eNeurologicalSci Date: 2021-12-03

5. Safe Transition to Pembrolizumab following Ipilimumab-Induced Guillain-Barré Syndrome: A Case Report and Review of the Literature.

Authors: Nicholas Gravbrot; Katalin Scherer; Srinath Sundararajan
Journal: Case Rep Oncol Med Date: 2019-11-22

6. Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report.

Authors: Sivraj Muralikrishnan; Lara K Ronan; Shodeinde Coker; Paula K Rauschkolb; Keisuke Shirai
Journal: Case Rep Oncol Date: 2020-01-21

Review 7. Immune Checkpoint Inhibitors and Neurotoxicity.

Authors: Zhiyi Zhao; Chunlin Zhang; Lian Zhou; Pan Dong; Lei Shi
Journal: Curr Neuropharmacol Date: 2021 Impact factor: 7.363

7 in total